Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (151-160 of 418) with videos related to

Pageof 42
Sort By:
Scientific Reports|September 8, 2018
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysisFrancesco Passiglia, Sergio Rizzo, Massimo Di Maio, et al.
Lung Cancer (Amsterdam, Netherlands)|August 29, 2015
Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) studySandro Barni, Evaristo Maiello, Massimo Di Maio, et al.
Clinical Lung Cancer|April 12, 2015
Treatment of Elderly Patients With Non-Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Lodovico Balducci, Fortunato Ciardiello, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2021
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic reviewClizia Zichi, Chiara Paratore, Piera Gargiulo, et al.
Cancer Treatment Reviews|March 13, 2022
Immunotherapy in advanced anal cancer: Is the beginning of a new era?Davide Ciardiello, Luigi Pio Guerrera, Brigida Anna Maiorano, et al.
The Lancet. Oncology|May 7, 2003
Statistical design in phase II clinical trials and its application in breast cancerFrancesco Perrone, Massimo Di Maio, Ermelinda De Maio, et al.
Anticancer Research|August 17, 2005
Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective studyCarmela Pisano, Stefano Greggi, Rosa Tambaro, et al.
Frontiers in Oncology|March 2, 2023
Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with <i>RAS/BRAF</i> wild type tumors at start of first line: The CAPRI 2 GOIM trialGiulia Martini, Davide Ciardiello, Stefania Napolitano, et al.
Critical Reviews in Oncology/Hematology|June 2, 2020
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectivesGianmarco Leone, Consuelo Buttigliero, Chiara Pisano, et al.
Oncology|October 12, 2011
Use of adjuvant therapy in patients with FIGO stage III endometrial carcinoma: a multicenter retrospective studyClaudia Marchetti, Carmela Pisano, Giorgia Mangili, et al.
Pageof 42

Showing results (151-160 of 418) with videos related to

Sort By:
Pageof 42
Scientific Reports|September 8, 2018
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysisFrancesco Passiglia, Sergio Rizzo, Massimo Di Maio, et al.
Lung Cancer (Amsterdam, Netherlands)|August 29, 2015
Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) studySandro Barni, Evaristo Maiello, Massimo Di Maio, et al.
Clinical Lung Cancer|April 12, 2015
Treatment of Elderly Patients With Non-Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Lodovico Balducci, Fortunato Ciardiello, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2021
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic reviewClizia Zichi, Chiara Paratore, Piera Gargiulo, et al.
Cancer Treatment Reviews|March 13, 2022
Immunotherapy in advanced anal cancer: Is the beginning of a new era?Davide Ciardiello, Luigi Pio Guerrera, Brigida Anna Maiorano, et al.
The Lancet. Oncology|May 7, 2003
Statistical design in phase II clinical trials and its application in breast cancerFrancesco Perrone, Massimo Di Maio, Ermelinda De Maio, et al.
Anticancer Research|August 17, 2005
Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective studyCarmela Pisano, Stefano Greggi, Rosa Tambaro, et al.
Frontiers in Oncology|March 2, 2023
Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with <i>RAS/BRAF</i> wild type tumors at start of first line: The CAPRI 2 GOIM trialGiulia Martini, Davide Ciardiello, Stefania Napolitano, et al.
Critical Reviews in Oncology/Hematology|June 2, 2020
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectivesGianmarco Leone, Consuelo Buttigliero, Chiara Pisano, et al.
Oncology|October 12, 2011
Use of adjuvant therapy in patients with FIGO stage III endometrial carcinoma: a multicenter retrospective studyClaudia Marchetti, Carmela Pisano, Giorgia Mangili, et al.
Pageof 42